Eagle Pharmaceuticals Inc (EGRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Eagle Pharmaceuticals Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 27 weeks, EGRX's average price target has gone down $1.33.
EGRX reports an average of 7.65% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
EGRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EGRX as an investment opportunity.
- Eagle Pharmaceuticals Inc's average analyst price target is greater than 85.17% of stocks in the small market cap category.
- EGRX has a higher upside potential (average analyst target price relative to current price) than 16.55% of Pharmaceutical Products stocks.
- Eagle Pharmaceuticals Inc's variance in analysts' estimates is less than 81.73% of Pharmaceutical Products stocks.
- Eagle Pharmaceuticals Inc's number of analysts covering the stock is higher than 22.88% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, NEOG, ANIP and DSGN are the three stocks most similar to Eagle Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is EGRX a Buy, Hold or Sell? See the POWR Ratings now!